BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37702371)

  • 1. Whole blood no-lyse no-wash micromethod for the quantitative measurement of monocyte HLA-DR.
    Miatello J; Faivre V; Marais C; Raineau M; Payen D; Tissieres P
    Cytometry B Clin Cytom; 2024 Jan; 106(1):58-63. PubMed ID: 37702371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study.
    Döcke WD; Höflich C; Davis KA; Röttgers K; Meisel C; Kiefer P; Weber SU; Hedwig-Geissing M; Kreuzfelder E; Tschentscher P; Nebe T; Engel A; Monneret G; Spittler A; Schmolke K; Reinke P; Volk HD; Kunz D
    Clin Chem; 2005 Dec; 51(12):2341-7. PubMed ID: 16214828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of mHLA-DR and nCD64 by Flow Cytometry to Study Dysregulated Host Response: The Use of QuantiBRITE™ PE Beads and Its Stability.
    Sanju S; Jain P; Priya VV; Varma PK; Mony U
    Appl Biochem Biotechnol; 2023 Sep; 195(9):5747-5752. PubMed ID: 35015219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.
    Spinetti T; Hirzel C; Fux M; Walti LN; Schober P; Stueber F; Luedi MM; Schefold JC
    Anesth Analg; 2020 Oct; 131(4):993-999. PubMed ID: 32925314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials.
    Quadrini KJ; Patti-Diaz L; Maghsoudlou J; Cuomo J; Hedrick MN; McCloskey TW
    Cytometry B Clin Cytom; 2021 Jan; 100(1):103-114. PubMed ID: 33432735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses-A
    Tamulyte S; Kopplin J; Brenner T; Weigand MA; Uhle F
    Front Immunol; 2019; 10():432. PubMed ID: 30915080
    [No Abstract]   [Full Text] [Related]  

  • 7. Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples.
    Demaret J; Walencik A; Jacob MC; Timsit JF; Venet F; Lepape A; Monneret G
    Cytometry B Clin Cytom; 2013; 84(1):59-62. PubMed ID: 22987669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of monocyte HLA-DR expression over time with secondary infection in critically ill children: a prospective observational study.
    Hagedoorn NN; Kolukirik P; Nagtzaam NMA; Nieboer D; Verbruggen S; Joosten KF; Moll H; Driessen G; Dik WA; Vermont C
    Eur J Pediatr; 2022 Mar; 181(3):1133-1142. PubMed ID: 34755207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary Intensive Care Unit.
    Manzoli TF; Troster EJ; Ferranti JF; Sales MM
    J Crit Care; 2016 Jun; 33():84-9. PubMed ID: 26928303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Real-Time Polymerase Chain Reaction Measurement of HLA-DRA Gene Expression in Whole Blood Is Highly Reproducible and Shows Changes That Reflect Dynamic Shifts in Monocyte Surface HLA-DR Expression during the Course of Sepsis.
    Cajander S; Tina E; Bäckman A; Magnuson A; Strålin K; Söderquist B; Källman J
    PLoS One; 2016; 11(5):e0154690. PubMed ID: 27144640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) Study.
    Peronnet E; Blein S; Venet F; Cerrato E; Fleurie A; Llitjos JF; Kreitmann L; Terraz G; Conti F; Gossez M; Rimmelé T; Textoris J; Lukaszewicz AC; Brengel-Pesce K; Monneret G;
    Crit Care Med; 2023 Jun; 51(6):808-816. PubMed ID: 36917594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Comparison of Monocyte Human Leukocyte Antigen-D-Related (mHLA-DR) Expression Levels Between Corona Virus Disease 2019 (COVID-19) Patients and Healthy Subjects.
    Nabilah MH; Wardhani P; Aryati A; Hernaningsih Y; Semedi BP
    Acta Med Indones; 2023 Jan; 55(1):52-60. PubMed ID: 36999265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma.
    Cheron A; Floccard B; Allaouchiche B; Guignant C; Poitevin F; Malcus C; Crozon J; Faure A; Guillaume C; Marcotte G; Vulliez A; Monneuse O; Monneret G
    Crit Care; 2010; 14(6):R208. PubMed ID: 21092108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR Expression on Monocyte Subsets in Critically Ill Children.
    Boeddha NP; Kerklaan D; Dunbar A; van Puffelen E; Nagtzaam NMA; Vanhorebeek I; Van den Berghe G; Hazelzet JA; Joosten KF; Verbruggen SC; Dik WA; Driessen GJ
    Pediatr Infect Dis J; 2018 Oct; 37(10):1034-1040. PubMed ID: 29570588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of neutrophil CD64 and monocyte HLA-DR measurement and its application in immune monitoring in kidney transplantation.
    Peng B; Yang M; Zhuang Q; Li J; Zhang P; Liu H; Cheng K; Ming Y
    Front Immunol; 2022; 13():1063957. PubMed ID: 36505404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated bedside flow cytometer for mHLA-DR expression measurement: a comparison study with reference protocol.
    Zouiouich M; Gossez M; Venet F; Rimmelé T; Monneret G
    Intensive Care Med Exp; 2017 Aug; 5(1):39. PubMed ID: 28856633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.
    Joshi I; Carney WP; Rock EP
    Front Immunol; 2023; 14():1130214. PubMed ID: 36825018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA-DR expression in clinical samples.
    Hamada S; Jeannet R; Gossez M; Cour M; Argaud L; Francois B; Daix T; Venet F; Monneret G
    Cytometry B Clin Cytom; 2022 Sep; 102(5):384-389. PubMed ID: 34117826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review.
    Benlyamani I; Venet F; Coudereau R; Gossez M; Monneret G
    Cytometry A; 2020 Dec; 97(12):1217-1221. PubMed ID: 33125816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low monocytic HLA-DR expression in critically ill patients of sepsis: An indicator for antimicrobial and/or immunomodulatory intervention.
    Ansari MA; Das S; Rai G; Singh PK; Lahan S; Tyagi A; Alamer E; Dar SA
    Transpl Immunol; 2023 Dec; 81():101942. PubMed ID: 37866671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.